Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-08-30 Sale | 2024-09-03 4:48 pm | JOHNSON & JOHNSON | JNJ | Decker Robert J VP Corporate Controller | 5,635 | $165.06 | $930,113 | 19,721 (Indirect Direct) | View |
| 2024-03-13 Sale | 2024-03-13 4:36 pm | JOHNSON & JOHNSON | JNJ | Broadhurst Vanessa EVP, Global Corp Affairs | 8,891 | $162.16 | $1,441,765 | 15,043 (Direct) | View |
| 2024-02-16 Sale | 2024-03-06 3:42 pm | CVRx Inc. | CVRX | JOHNSON & JOHNSON Johnson & Johnson Innovation - JJDC Inc. 10% Owner | 3,725 | $25.81 | $96,142 | 4,103,430 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-05-01 Exercise(A) | 2024-10-31 5:57 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | REED JOHN C EVP, Innovative Medicine, R&D | 25,255 | $0 | 65,087 (Direct) | View |
| 2024-05-01 Tax Withholding(A) | 2024-10-31 5:57 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | REED JOHN C EVP, Innovative Medicine, R&D | 10,984 | $144.59 | 65,087 (Direct) | View |
| 2024-05-22 Gift | 2024-10-21 6:18 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Wolk Joseph J Exec VP, CFO | 137,725 | $0 | 70,930 (Direct) | View |
| 2024-04-25 Option Award | 2024-10-15 4:39 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | DAVIS D SCOTT Director | 1,386 | $0 | 15,604 (Direct) | View |
Ownership | 2024-10-09 5:07 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Mulholland Kristen EVP, Chief HR Officer | 0 | $0 | 95,211 (Direct) | View |
| 2024-09-10 Option Award | 2024-09-12 4:44 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Woods Eugene A. Director | 188 | $165.94 | 2,574 (Direct) | View |
| 2024-09-10 Option Award | 2024-09-12 4:43 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | HEWSON MARILLYN A Director | 303 | $165.94 | 10,955 (Direct) | View |
| 2024-08-30 Exercise | 2024-09-03 4:48 pm | 2018-02-10 2025-02-09 | JOHNSON & JOHNSON | JNJ | Decker Robert J VP Corporate Controller | 5,635 | $0 | 19,721 (Direct) | View |
| 2024-08-30 Exercise | 2024-09-03 4:48 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Decker Robert J VP Corporate Controller | 5,635 | $100.06 | 19,721 (Direct) | View |
| 2024-07-08 Tax Withholding | 2024-07-09 5:48 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Broadhurst Vanessa EVP, Global Corp Affairs | 5,018 | $147.16 | 19,834 (Direct) | View |
| 2024-07-08 Exercise | 2024-07-09 5:48 pm | 2024-07-01 N/A | JOHNSON & JOHNSON | JNJ | Broadhurst Vanessa EVP, Global Corp Affairs | 9,809 | $0 | 19,834 (Direct) | View |
| 2024-06-04 Option Award | 2024-06-06 5:07 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Woods Eugene A. Director | 211 | $147.85 | 2,368 (Direct) | View |
| 2024-06-04 Option Award | 2024-06-06 5:07 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | HEWSON MARILLYN A Director | 315 | $147.85 | 10,573 (Direct) | View |
| 2024-05-01 Exercise | 2024-05-03 4:31 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | REED JOHN C EVP, Innovative Medicine, R&D | 22,255 | $0 | 65,087 (Direct) | View |
| 2024-05-01 Tax Withholding | 2024-05-03 4:31 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | REED JOHN C EVP, Innovative Medicine, R&D | 10,984 | $144.59 | 65,087 (Direct) | View |
| 2024-04-25 Option Award | 2024-04-29 5:06 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Beckerle Mary C Director | 1,386 | $0 | 13,643 (Direct) | View |
| 2024-04-25 Option Award | 2024-04-29 5:06 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | HEWSON MARILLYN A Director | 1,386 | $0 | 10,173 (Direct) | View |
| 2024-04-25 Option Award | 2024-04-29 5:06 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | West Nadja Director | 1,386 | $0 | 5,094 (Direct) | View |
| 2024-04-25 Option Award | 2024-04-29 5:06 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Adamczyk Darius Director | 1,386 | $0 | 3,713 (Direct) | View |
| 2024-04-25 Option Award | 2024-04-29 5:06 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Woods Eugene A. Director | 1,386 | $0 | 2,139 (Direct) | View |
| 2024-04-25 Option Award | 2024-04-29 5:06 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | MULCAHY ANNE M Director | 1,386 | $0 | 21,471 (Direct) | View |
| 2024-04-25 Option Award | 2024-04-29 5:06 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | WEINBERGER MARK A Director | 1,386 | $0 | 9,129 (Direct) | View |
| 2024-04-25 Option Award | 2024-04-29 5:06 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | McClellan Mark B. Director | 1,386 | $0 | 17,868 (Direct) | View |
| 2024-04-25 Option Award | 2024-04-29 5:05 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Joly Hubert Director | 1,386 | $0 | 6,464 (Direct) | View |
| 2024-04-25 Option Award | 2024-04-29 5:05 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Johnson Paula A Director | 1,386 | $0 | 2,859 (Direct) | View |
| 2024-04-25 Option Award | 2024-04-29 5:05 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Doudna Jennifer A Director | 1,386 | $0 | 8,082 (Direct) | View |
Ownership | 2024-04-10 5:05 pm | N/A N/A | Contineum Therapeutics Inc. | CTNM | JOHNSON & JOHNSON Johnson & Johnson Innovation - JJDC Inc. 10% Owner | 0 | $0 | 1,979,173 (Indirect) | View |
| 2024-03-05 Option Award | 2024-03-07 4:58 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Woods Eugene A. Director | 753 | $159.8 | 1,245 (Direct) | View |
| 2024-03-05 Option Award | 2024-03-07 4:58 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | HEWSON MARILLYN A Director | 235 | $159.8 | 8,788 (Direct) | View |
| 2024-02-29 Exercise | 2024-03-06 3:42 pm | N/A N/A | CVRx Inc. | CVRX | JOHNSON & JOHNSON Johnson & Johnson Innovation - JJDC Inc. 10% Owner | 584 | $1.186 | 4,103,430 (Indirect) | View |
| 2024-02-16 Exercise | 2024-03-06 3:42 pm | N/A N/A | CVRx Inc. | CVRX | JOHNSON & JOHNSON Johnson & Johnson Innovation - JJDC Inc. 10% Owner | 607,725 | $0.158 | 4,103,430 (Indirect) | View |
| 2024-02-29 Exercise | 2024-03-06 3:42 pm | N/A N/A | CVRx Inc. | CVRX | JOHNSON & JOHNSON Johnson & Johnson Innovation - JJDC Inc. 10% Owner | 2,940 | $0.237 | 4,103,430 (Indirect) | View |
| 2024-02-29 Exercise | 2024-03-06 3:42 pm | N/A 2024-11-18 | CVRx Inc. | CVRX | JOHNSON & JOHNSON Johnson & Johnson Innovation - JJDC Inc. 10% Owner | 3,855 | $0 | 4,103,430 (Indirect) | View |
| 2024-02-29 Exercise | 2024-03-06 3:42 pm | N/A N/A | CVRx Inc. | CVRX | JOHNSON & JOHNSON Johnson & Johnson Innovation - JJDC Inc. 10% Owner | 79 | $5.141 | 4,103,430 (Indirect) | View |
| 2024-02-16 Exercise | 2024-03-06 3:42 pm | N/A N/A | CVRx Inc. | CVRX | JOHNSON & JOHNSON Johnson & Johnson Innovation - JJDC Inc. 10% Owner | 607,225 | $0 | 4,103,430 (Indirect) | View |
| 2024-02-29 Exercise | 2024-03-06 3:42 pm | N/A N/A | CVRx Inc. | CVRX | JOHNSON & JOHNSON Johnson & Johnson Innovation - JJDC Inc. 10% Owner | 252 | $3.955 | 4,103,430 (Indirect) | View |
| 2024-02-15 Option Award | 2024-02-20 5:58 pm | N/A 2034-02-15 | JOHNSON & JOHNSON | JNJ | Taubert Jennifer L EVP, WWC. Innovative Medicine | 81,763 | $0 | 81,763 (Direct) | View |
| 2024-02-15 Option Award | 2024-02-20 5:56 pm | N/A 2034-02-15 | JOHNSON & JOHNSON | JNJ | Wengel Kathryn E EVP, Chief TO and Risk Officer | 31,094 | $0 | 31,094 (Direct) | View |
| 2024-02-15 Option Award | 2024-02-20 5:56 pm | N/A 2034-02-15 | JOHNSON & JOHNSON | JNJ | Schmid Timothy EVP, WW Chair, MedTech | 52,743 | $0 | 52,743 (Direct) | View |
| 2024-02-15 Option Award | 2024-02-20 5:55 pm | N/A 2034-02-15 | JOHNSON & JOHNSON | JNJ | Hait William EVP, Chief EI and Med Officer | 36,851 | $0 | 36,851 (Direct) | View |
| 2024-02-15 Option Award | 2024-02-20 5:55 pm | N/A 2034-02-15 | JOHNSON & JOHNSON | JNJ | Swanson James D. EVP, CIO | 25,220 | $0 | 25,220 (Direct) | View |
| 2024-02-15 Option Award | 2024-02-20 5:55 pm | N/A 2034-02-15 | JOHNSON & JOHNSON | JNJ | REED JOHN C EVP, Innovative Medicine, R&D | 69,211 | $0 | 69,211 (Direct) | View |
| 2024-02-15 Option Award | 2024-02-20 5:55 pm | N/A 2034-02-15 | JOHNSON & JOHNSON | JNJ | Wolk Joseph J Exec VP, CFO | 101,110 | $0 | 101,110 (Direct) | View |
| 2024-02-15 Option Award | 2024-02-20 5:55 pm | N/A 2034-02-15 | JOHNSON & JOHNSON | JNJ | Forminard Elizabeth Executive VP, General Counsel | 49,289 | $0 | 49,289 (Direct) | View |
| 2024-02-15 Option Award | 2024-02-20 5:54 pm | N/A 2034-02-15 | JOHNSON & JOHNSON | JNJ | Duato Joaquin CEO and Chairman of the Board | 188,862 | $0 | 188,862 (Direct) | View |
| 2024-02-15 Option Award | 2024-02-20 5:54 pm | N/A 2034-02-15 | JOHNSON & JOHNSON | JNJ | Fasolo Peter Exec VP, Chief HR Officer | 43,070 | $0 | 43,070 (Direct) | View |
| 2024-02-15 Option Award | 2024-02-20 5:54 pm | N/A 2034-02-15 | JOHNSON & JOHNSON | JNJ | Broadhurst Vanessa EVP, Global Corp Affairs | 25,220 | $0 | 25,220 (Direct) | View |
| 2024-02-15 Option Award | 2024-02-20 5:54 pm | N/A 2034-02-15 | JOHNSON & JOHNSON | JNJ | Decker Robert J VP Corporate Controller | 9,191 | $0 | 9,191 (Direct) | View |
| 2024-02-13 Exercise | 2024-02-15 4:53 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Wengel Kathryn E EVP, Chief TO and Risk Officer | 651 | $0 | 83,913 (Direct) | View |
| 2024-02-13 Tax Withholding | 2024-02-15 4:53 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Wengel Kathryn E EVP, Chief TO and Risk Officer | 333 | $157.85 | 83,913 (Direct) | View |